期刊文献+

胃肠道间质瘤临床病理特点及诊治分析 被引量:7

Analysis of pathological characteristics,diagnosis and treatment of gastrointestinal stromal tumors
下载PDF
导出
摘要 目的探讨胃肠道间质瘤(GIST)临床病理特点及诊治情况。方法对31例GIST患者的临床资料进行回顾性分析。结果全部患者均行手术治疗。31例GIST患者发生部位以胃(19例61.3%)和空肠(6例19.3%)为主。首发症状以腹痛、腹胀(20例64.5%)和消化道出血(12例38.7%)、腹部包块(8例25.8%)为主要表现。病理报告良性13例、潜在恶性2例、恶性16例。免疫组化CD117阳性28例(90.3%),CD34阳性26例(83.9%)。结论(1)GIST消化道症状无特异性,术前确诊率低,易造成误诊;(2)CD117和CD34阳性可以作为GIST的诊断标志;(3)治疗应以局部切除为主,恶性者应扩大切除范围。 Objective To investigate the clinicopathological characteristics and dlagnosis-treatment conditions of gastrointestinal stromal tumors(GIST). Methods Clinical data of 31 patients with GIST were analyzed retrospectively. Results All 31 patients underwent surgery for their tumors. The tumors were mainly situated in stomach (19 cases,61.3% )and in jejunum (6 cases, 19.3% ). Among the 31 cases, people firstly complained with abdominalgia and abdominal distention(20 cases, 64.5% ), gastrointestinal bleeding(12 cases,38.7% ) ,and abdominal mass (8 cases, 25.8% ). Postoperative pathology revealed that there were 13 benign cases,2 occult malignant cases and 16 malignant cases. The positive rates by immunohistochemical methods for CDll7 and CD34 were 90.3% (28/31) and 83.9% (26/31)respectively. Conclusions (1)There are a low preoperative diagnostic rate and a high misdiagnosis in GIST for their nonspecific digestive symptoms, (2)CD117 and CD34 can be used as biological markers in the diagnosis of GIST, (3) Toporesection seem to be the principal treatment method for GIST . But in malignant ones, we should enlarge the resection.
出处 《实用肿瘤学杂志》 CAS 2008年第4期326-327,312,共3页 Practical Oncology Journal
关键词 胃肠道间质瘤 免疫组化 诊断 治疗 Gastrointestinal stromal tumor (GIST) Immunohistochemistry Diagnosis Treatment
  • 相关文献

参考文献6

  • 1Mazur MT, Clark HB. Gastric stromal tumors, Reappraisal of histogenesis[J]. Am J Surg Pathol, 1983, 7 (6) :507-519
  • 2Hirota S,Isozaki K, Moriyama Y, et al. Gain of function mutation of c-kit in human gastrointestinal stromal tumors[J].Science, 1998,279(5350) : 577-580
  • 3De matteo RP,Leung D, Two hundred gastrointestinal stromal tumors[J]. Ann Surg,2000,231 : 51-58
  • 4罗容珍,梁小曼,何洁华,侯景辉,饶慧兰.154例胃肠道间质瘤的临床病理及免疫组化特征[J].广东医学,2004,25(3):244-246. 被引量:18
  • 5叶颖江,王志强,王杉.胃肠间质瘤诊断和治疗进展[J].中华胃肠外科杂志,2007,10(1):91-94. 被引量:25
  • 6Pierie J, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors [J].Arch Surg,2001,136(4):383-389

二级参考文献12

  • 1黄文斌,陈洁宇,周晓军.PKCθ:一个新的诊断胃肠道间质肿瘤(GIST),特别是KIT阴性表达的GIST的免疫组化标记物[J].临床与实验病理学杂志,2005,21(4):441-441. 被引量:20
  • 2贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 3詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 4Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histdogical, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001, 438:1.
  • 5Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol, 1995,103:41.
  • 6Dematteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors.Ann Surg,2000,231:51
  • 7Emory TS, Sobin LL,Lukus L, et al. Prognosis of gastrointestinal smooth-muscle(stromal)tumors. Am J Surg Pathd, 1999, 23(1):82.
  • 8Reith JD, Goldblum JR, Lyles RH, et al.Extragastrointestinal(soft tissue)stromal tumors: an analysis of 48 cases with emphasis on histotogic predictors of outcome. Mod Pathol, 2000,13(5):577.
  • 9Tazawa K, Tsukada T, Makuuchi H, et al. An immunohistochemical and clincopathdogical study of gastrointestinal stromal tumors. Pathology international, 1999, 49: 786.
  • 10Miettinen M, Sobin LH, Sarlomo- Rikala M, et al.Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT).Mod Pathol,2000,13(10):1134

共引文献40

同被引文献1673

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部